3Christensen E. Choosing the best endpoint[J].J Hepatol,2008, 49(4) :672- 673.
4Tan B J, Liu Y, Chang K L, et al. Perorally active nanomicellarformulation of quercetin in the treatment of lung cancer[J]. Int J Nanomedicine, 2012,7(6) : 651-661.
5Peixoto P M, Lue J K, Ryu S Y, etal. Mitochondrial apoptosis- induced channel (MAC) function triggers a Bax/Bak-dependent bystander effect[J]. Am J Pathol,2011,178(1) :48-54.
6Zhang Y, Xu X, He P. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells[J].Mol Med Report,2011,4(1) ;25-29.
7Lu H F, Chic Y J, Yang M S, et al. Apigenin induces caspase- dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway[J]. Int J Oncol, 2010,36 (6) : 1477-1484.
8Jin S M, Cho H J, Jung M W, et al. DNA damage-inducing agent-elicited gamma-secretase activity is dependent on Bax/Bcl- 2 pathway but not on caspase cascades[J]. Cell Death Differ, 2007,14( 1 ) : 189-192.
9Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J]. FertilSteril,2004,81(1):19- 25.
4Kalemkerian GP,Akerley W, B ogner P,et al. Small cel lung cancer[J ].J Nat Compr Cane Netw, 2013,11 ( 1 ) : 78-98.
5Birsoy K. Possemato R. Lorbeer FK. et al. Metabolic de- terminants of cancer cell sensitivity to glucose limitation and biguanides[J]. Nature,2014,508(7494) : 108-112.
6Hsieh MC,Lee TC,Cheng SM,et al. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwan Residents[J]. Exp Diabetes Res,2012,doi: 10.1155/ 2012/413782.
7Libby G,Donnelly LA,Donnan PT,et al. New users of mefforrnin are at low risk of incident eaneer:a cohort study among people with type 2 diabetes[J]. Diabetes Care, 2009,32(9) : 1620-1625.
8Mazzone PJ,Rai H,Beukemann M,et al. The effect of metformin and thiazolidinedione use on lung cancer in diabetics[J]. BMC Cancer,2012,14(12) :410.
9Smiechowski BB,Azoulay L,Yin H,et al. The use of met- formin and the incidence of lung cancer in patients with type 2 diabetes[J].Diabetes Care, 2013,36( 1 ) : 124-129.
10Zhang ZJ,Bi Y,Li S,et al. Reduced risk of lung cancer with metformin therapy in diabetic patients:A systematic review and meta-analysis[J]. Am J Epidemiol,2014,180(1) : 11-14.
